Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO
Group 1 - Eikon Therapeutics raised $381.2 million in its U.S. initial public offering [1] - The company sold approximately 21.2 million shares at a price of $18 each [1]
Group 1 - Eikon Therapeutics raised $381.2 million in its U.S. initial public offering [1] - The company sold approximately 21.2 million shares at a price of $18 each [1]